Ironwood Pharmaceuticals, Inc. (IRWD)
4.125
-0.16
(-3.85%)
USD |
NASDAQ |
Aug 24, 16:00
4.14
+0.02
(+0.36%)
After-Hours: 20:00
Ironwood Pharmaceuticals Shareholders Equity (Quarterly) : -161.84M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -161.84M |
| March 31, 2026 | -217.14M |
| December 31, 2025 | -261.84M |
| September 30, 2025 | -264.16M |
| June 30, 2025 | -308.16M |
| March 31, 2025 | -334.05M |
| December 31, 2024 | -301.34M |
| September 30, 2024 | -311.33M |
| June 30, 2024 | -321.73M |
| March 31, 2024 | -330.52M |
| December 31, 2023 | -346.30M |
| September 30, 2023 | -323.22M |
| June 30, 2023 | -345.70M |
| March 31, 2023 | 706.85M |
| December 31, 2022 | 652.38M |
| September 30, 2022 | 591.06M |
| June 30, 2022 | 532.88M |
| March 31, 2022 | 517.78M |
| December 31, 2021 | 605.91M |
| September 30, 2021 | 579.94M |
| June 30, 2021 | 511.76M |
| March 31, 2021 | 110.19M |
| December 31, 2020 | 62.64M |
| September 30, 2020 | 5.904M |
| June 30, 2020 | -36.85M |
| Date | Value |
|---|---|
| March 31, 2020 | -71.56M |
| December 31, 2019 | -93.25M |
| September 30, 2019 | -153.05M |
| June 30, 2019 | -219.37M |
| March 31, 2019 | -237.18M |
| December 31, 2018 | -196.37M |
| September 30, 2018 | -197.30M |
| June 30, 2018 | -43.95M |
| March 31, 2018 | -18.05M |
| December 31, 2017 | 9.848M |
| September 30, 2017 | -17.58M |
| June 30, 2017 | 4.87M |
| March 31, 2017 | 29.64M |
| December 31, 2016 | 66.72M |
| September 30, 2016 | 59.46M |
| June 30, 2016 | 81.38M |
| March 31, 2016 | 90.94M |
| December 31, 2015 | 95.12M |
| September 30, 2015 | 100.46M |
| June 30, 2015 | 140.28M |
| March 31, 2015 | 68.16M |
| December 31, 2014 | 88.55M |
| September 30, 2014 | 108.15M |
| June 30, 2014 | 141.83M |
| March 31, 2014 | 188.94M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| AbbVie, Inc. | -5.935B |
| Rigel Pharmaceuticals, Inc. | 425.42M |
| Marker Therapeutics, Inc. | 12.17M |
| Verastem, Inc. | 49.99M |
| Theriva Biologics, Inc. | 12.19M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 285.13M |
| Total Liabilities (Quarterly) | 446.97M |
| Debt to Equity Ratio | -2.452 |
| Current Ratio | 6.063 |
| Net Debt Paydown Yield | 5.81% |